Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07448337) titled 'Psoriasis Comorbidities at Hospital Calderón Guardia' on Feb. 26.

Study Type: Observational

Primary Sponsor: Caja Costarricense de Seguro Social

Condition: Psoriasis Psoriasis Arthritis Psoriasis (PsO) Psoriasis Patients

Recruitment Status: Not recruiting

Date of First Enrollment: May 2026

Target Sample Size: 350

Countries of Recruitment: Costa Rica

To know more, visit https://clinicaltrials.gov/study/NCT07448337

Published by HT Digital Content Services with permission from Health Daily Digest....